Emerging trends and new developments in regenerative medicine: a scientometric update (2000 – 2014)

Bibliography

• Cherry AB, Daley GQ. Reprogramming cellular identity for regenerative medicine. Cell 2012;148:1110-22
   PubMed Web of Science ®Google Scholar
• Chen FM, Zhao YM, Jin Y, et al. Prospects for translational regenerative medicine. Biotechnol Adv 2012;30:658-72
   PubMed Web of Science ®Google Scholar
• Zacharias DG, Nelson TJ, Mueller PS, et al. The Science and ethics of induced pluripotency: what will become of embryonic stem cells? Mayo Clinic Proc 2011;86:634-40
   PubMed Web of Science ®Google Scholar
• Levi B, Longaker MT. Concise review: adipose-derived stromal cells for skeletal regenerative medicine. Stem Cells 2011;29:576-82
   PubMed Web of Science ®Google Scholar
• Gurdon JB. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol 1962;10:622-40
   PubMedGoogle Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76
   PubMed Web of Science ®Google Scholar
• Campbell KH, McWhir J, Ritchie WA, et al. Sheep cloned by nuclear transfer from a cultured cell line. Nature 1996;380:64-6
   PubMed Web of Science ®Google Scholar
• Xu YX, Sheng KX, Li C, et al. Self-assembled graphene hydrogel via a one-step hydrothermal process. ACS Nano 2010;4:4324-30
   PubMed Web of Science ®Google Scholar
• Stadtfeld M, Hochedlinger K. Induced pluripotency: history mechanisms and applications. Genes Dev 2010;24:2239-63
   PubMed Web of Science ®Google Scholar
• Chen C, Hu Z, Liu S, et al. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace. Expert Opin Biol Ther 2012;12:593-608
   PubMed Web of Science ®Google Scholar
• Chen GY, Pang DW, Hwang SM, et al. A graphene-based platform for induced pluripotent stem cells culture and differentiation. Biomaterials 2012;33:418-27
   PubMed Web of Science ®Google Scholar
• Lu J, He YS, Cheng C, et al. Self-supporting graphene hydrogel film as an experimental platform to evaluate the potential of graphene for bone regeneration. Adv Funct Mater 2013;23:3494-502
   Web of Science ®Google Scholar
• Ruella M, Kalos M. Adoptive immunotherapy for cancer. Immunol Rev 2014;257:14-38
   PubMed Web of Science ®Google Scholar
• Itzhaki I, Maizels L, Huber I, et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011;471:225-9
   PubMed Web of Science ®Google Scholar
• Hong H, Takahashi K, Ichisaka T, et al. Suppression of induced pluripotent stem cell generation by the p53–p21 pathway. Nature 2009;460:1132-5
   PubMed Web of Science ®Google Scholar
• Zhao T, Zhang Z-N, Rong Z, et al. Immunogenicity of induced pluripotent stem cells. Nature 2011;474:212-15
   PubMed Web of Science ®Google Scholar
• Gore A, Li Z, Fung H-L, et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011;471:63-7
   PubMed Web of Science ®Google Scholar
• Shi Y, Tae Do J, Desponts C, et al. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2008;2:525-8
   PubMed Web of Science ®Google Scholar
• Woltjen K, Michael IP, Mohseni P, et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009;458:766-70
   PubMed Web of Science ®Google Scholar
• Okita K, Yamakawa T, Matsumura Y, et al. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 2013;31:458-66
   PubMed Web of Science ®Google Scholar
• Obokata H, Wakayama T, Sasai Y, et al. Stimulus-triggered fate conversion of somatic cells into pluripotency. Nature 2014;505:641-7
   PubMed Web of Science ®Google Scholar
• Ieda M, Fu J-D, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010;142:375-86
   PubMed Web of Science ®Google Scholar
• Vierbuchen T, Ostermeier A, Pang ZP, et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010;463:1035-41
   PubMed Web of Science ®Google Scholar
• Chen C, Leydesdorff L. Patterns of connections and movements in dual-map. overlays: a new method of publication portfolio analysis. J Assoc Info Sci Technol 2014;65:334-51
   Web of Science ®Google Scholar
• Chen C. Predictive effects of structural variation on citation counts. J Am Soc Info Sci Technol 2012;63:431-49
   Web of Science ®Google Scholar
• Cobo MJ, Lopez-Herrera AG, Herrera-Viedma E, et al. Science mapping software tools: review, analysis, and cooperative study among tools. J Am Soc Info Sci Technol 2011;62:1382-402
   Web of Science ®Google Scholar
• Chen CM. CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Info Sci Technol 2006;57:359-77
   Web of Science ®Google Scholar
• Chen C. Searching for intellectual turning points: progressive Knowledge Domain Visualization. Proc Natl Acad Sci USA 2004;101:5303-10
   PubMed Web of Science ®Google Scholar
• Chen C, Ibekwe-SanJuan F, Hou J. The structure and dynamics of co-citation clusters: a multiple-perspective co-citation analysis. J Am Soc Info Sci Technol 2010;61:1386-409
   Web of Science ®Google Scholar
• Small H. Co-citation in the scientific literature: a new measure of the relationship between two documents. J Am Soc Info Sci Technol 1973;24:265-9
   Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74
   PubMed Web of Science ®Google Scholar
• Kim K, Doi A, Wen B, et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010;467:285-90
   PubMed Web of Science ®Google Scholar
• Anokye-Danso F, Trivedi CM, Juhr D, et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011;8:376-88
   PubMed Web of Science ®Google Scholar
• Dasha M, Chiellinia F, Ottenbriteb RM, et al. Chitosan - a versatile semi-synthetic polymer in biomedical applications. Prog Polym Sci 2011;36:981-1014
   Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72
   PubMed Web of Science ®Google Scholar
• Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater 2009;5:1-13
   PubMed Web of Science ®Google Scholar
• Bolli R, Chugh AR, D’Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised Phase 1 trial. Lancet 2011;378:1847-57
   PubMed Web of Science ®Google Scholar
• Rosvall M, Bergstrom CT. Mapping change in large networks. PLoS One 2010;e8694
   Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7
   PubMed Web of Science ®Google Scholar
• Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154-6
   PubMed Web of Science ®Google Scholar
• Kiskinis E, Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest 2010;120:51-9
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-11
   PubMed Web of Science ®Google Scholar
• Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-9
   PubMed Web of Science ®Google Scholar
• Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005;307:58-62
   PubMed Web of Science ®Google Scholar
• Warren L, Manos PD, Ahfeldt T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010;7:618-30
   PubMed Web of Science ®Google Scholar
• Lister R, Pelizzola M, Kida YS, et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011;471:68-73
   PubMed Web of Science ®Google Scholar
• Slaughter BV, Khurshid SS, Fisher OZ, et al. Hydrogels in regenerative medicine. Adv Mater 2009;21:3307-29
   PubMed Web of Science ®Google Scholar
• Polo JM, Liu S, Figueroa ME, et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 2010;28:845-55
   Google Scholar
• Liu SQ, Tay R, Khan M, et al. Synthetic hydrogels for controlled stem cell differentiation. Soft Matter 2010;6:67-81
   Web of Science ®Google Scholar
• Kim D-H, Lee H, Lee YK, et al. Biomimetic nanopatterns as enabling tools for analysis and control of live cells. Adv Mater 2010;22:4551-66
   PubMed Web of Science ®Google Scholar
• Pattersona J, Martinoa MM, Hubbell JA. Biometric materials in tissue engineering. Mater Today 2010;13:14-22
   Web of Science ®Google Scholar
• Roacha P, Parkerb T, Gadegaardc N, et al. Surface strategies for control of neuronal cell adhesion: a review. Surf Sci Rep 2010;65:145-73
   Web of Science ®Google Scholar
• Teo BK, Ankam S, Chan LY, et al. Nanotopography/mechanical induction of stem-cell differentiation. Methods Cell Biol 2010;98:241-94
   PubMed Web of Science ®Google Scholar
• Elloumi-Hannachi I, Yamato M, Okano T. Cell sheet engineering: a unique nanotechnology for scaffold-free tissue reconstruction with clinical applications in regenerative medicine. J Intern Med 2010;267:54-70
   PubMed Web of Science ®Google Scholar
• Kelm JM, Fussenegger M. Scaffold-fee cell delivery for use in regenerative medicine. Adv Drug Deliv Rev 2010;62:753-64
   PubMed Web of Science ®Google Scholar
• Itogaa K, Okanoa T. The high functionalization of temperature-responsive culture dishes for establishing advanced cell sheet engineering. J Mater Chem 2010;20:8768-75
   Web of Science ®Google Scholar
• Egami M, Haraguchi Y, Shimizu T, et al. Latest status of the clinical and industrial applications of cell sheet engineering and regenerative engineering. Arch Pharm Res 2014;37:96-106
   PubMed Web of Science ®Google Scholar
• Stasi AD, Tey S-K, Dotti G, et al. Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med 2011;365:1673-83
   PubMed Web of Science ®Google Scholar
• Porter DL, Levine BL, Kalos M, et al. Chimeric antigen receptor–modified t cells in chronic lymphoid leukemia. N Engl J Med 2011;365:725-33
   PubMed Web of Science ®Google Scholar
• Tormin A, Li O, Brune JC, et al. CD146 Expression on Primary Nonhematopoietic Bone Marrow Stem Cells Is Correlated with in Situ Localization. Blood 2011;117:5067-77
   PubMed Web of Science ®Google Scholar
• Brentjens RJ, Rivière I, Park JH, et al. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory b-cell leukemias. Blood 2011;118:4817-28
   PubMed Web of Science ®Google Scholar
• Savoldo B, Ramos CA, Liu E, et al. CD28 costimulation improves expansion and persistence of chimeric antigen receptor - modified t cells in lymphoma patients. J Clin Invest 2011;121:1822-6
   PubMed Web of Science ®Google Scholar
• Dotti G, Gottschalk S, Savoldo B, et al. Design and Development of Therapies Using Chimeric Antigen Receptor-Expressing T Cells. Immunol Rev 2014;257:107-26
   PubMed Web of Science ®Google Scholar
• Jensen MC, Riddell SR. Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells. Immunol Rev 2014;257:127-44
   PubMed Web of Science ®Google Scholar
• Turtle CJ, Hudecek M, Jensen MC, et al. Engineered T cells for anti-cancer therapy. Curr Opin Immunol 2012;24:633-9
   PubMed Web of Science ®Google Scholar
• Burdick JA, Prestwich GD. Hyaluronic acid hydrogels for biomedical applications. Adv Mater 2011;23:H41-56
   PubMed Web of Science ®Google Scholar
• Ott HC, Matthiesen TS, Goh S-K, et al. Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat Med 2008;14:213-21
   PubMed Web of Science ®Google Scholar
• Dvir T, Timko BP, Kohane DS, et al. Nanotechnological strategies for engineering complex tissues. Nat Nanotechnol 2011;6:13-22
   PubMed Web of Science ®Google Scholar
• Macchiarini P, Jungebluth P, Go T, et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008;372:2023-30
   PubMed Web of Science ®Google Scholar
• Uygun BE, Soto-Gutierrez A, Yagi H, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010;16:814-20
   PubMed Web of Science ®Google Scholar
• Lee K, Silva EA, Mooney DJ. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface 2011;8:153-70
   PubMed Web of Science ®Google Scholar
• Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials 2011;32:3233-43
   PubMed Web of Science ®Google Scholar
• Chen FM, Zhang M, Wu ZF. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 2010;31:6279-308
   PubMed Web of Science ®Google Scholar
• Hoppe A, Güldal NS, Boccaccini AR. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials 2011;32:2757-74
   PubMed Web of Science ®Google Scholar
• Hare JM, Traverse JH, Henry TD, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009;54:2277-86
   PubMed Web of Science ®Google Scholar
• Makkar RR, Smith RR, Cheng K, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012;379:895-904
   PubMed Web of Science ®Google Scholar
• Williams AR, Hare JM. Mesenchymal Stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 2011;109:923-40
   PubMed Web of Science ®Google Scholar
• Karussis D, Karageorgiou C, Vaknin-Dembinsky A, et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 2010;67:1187-94
   PubMed Web of Science ®Google Scholar
• Sommer CA, Mostoslavsky G. Experimental approaches for the generation of induced pluripotent stem cells. Stem Cell Res Ther 2010;1:26
   PubMedGoogle Scholar
• Watt FM, Driskell RR. The therapeutic potential of stem cells. Philos Trans R Soc Lond B Biol Sci 2010;365:155-63
   PubMed Web of Science ®Google Scholar
• Hanley J, Rastegarlari G, Nathwani AC. An introduction to induced pluripotent stem cells. Br J Haematol 2010;151:16-24
   PubMed Web of Science ®Google Scholar
• Schnerch A, Cerdan C, Bhatia M. Distinguishing between mouse and human pluripotent stem cell regulation: the best laid plans of mice and men. Stem Cells 2010;28:419-30
   PubMed Web of Science ®Google Scholar
• Ralston A, Rossant J. The genetics of induced pluripotency. Reproduction 2010;139:35-44
   PubMedGoogle Scholar
• Lowry WE, Quan WL. Roadblocks en route to the clinical application of induced pluripotent stem cells. J Cell Sci 2010;123:643-51
   PubMed Web of Science ®Google Scholar
• Chang DF, Tsai SC, Wang XC, et al. Molecular characterization of the human NANOG protein. Stem Cells 2009;27:812-21
   PubMed Web of Science ®Google Scholar
• Anastasia L, Pelissero G, Venerando B, et al. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine. Cell Death Differ 2010;17:1230-7
   PubMed Web of Science ®Google Scholar